Donna Rowen
BA, MSc, PhD (Sheffield)
Population Health, School of Medicine and Population Health
Professor of Health Economics
+44 114 222 0728
Full contact details
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
- Profile
-
I joined HEDS as a health economist in September 2006. Prior to joining HEDS I worked as a teaching assistant in Economics at the University of Sheffield whilst undertaking a PhD in Economics.
- Research interests
-
- Measuring and valuing health and quality of life
- Measuring and valuing child health
- Methodology of developing preference-based measures of health from existing measures
- Mapping between measures to generate utility values
I lead and undertake research and consultancy projects in health economics, particularly relating to deriving health state utility values. I have been involved in the development of several condition-specific preference-based measures from existing instruments including cancer, dementia, diabetes, epilepsy, flushing, common mental health problems and myelofibrosis, and provides advice to the NICE Decision Support Unit. I have also undertaken NICE DSU technical support documents for estimating utilities focussing on mapping and alternative measures to EQ-5D. I have also estimated societal values for burden of illness and end of life as part of EEPRU.
Current projects
My current projects include a study assessing the equivalence of preference elicitation interviews undertaken online and face-to-face to inform the UK valuation of EQ-5D-5L. I am also working on the MACUSTAR project, which involves generating a preference-based measure for dry age-related macular degeneration.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- A systematic review of the methodologies and modelling approaches used to generate international EQ-5D-5L value sets. PharmacoEconomics. View this article in WRRO
- Review of valuation methods of preference-based measures of health for economic evaluation in child and adolescent populations: Where are we now and where are we going?. PharmacoEconomics, 38(4), 325-340. View this article in WRRO
- PROM validation using paper-based or online surveys : data collection methods affect the sociodemographic and health profile of the sample. Value in Health, 22(8), 845-850. View this article in WRRO
- An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy, 17(3), 295-313. View this article in WRRO
- Estimating a Dutch value set for the paediatric preference-based CHU-9D using a discrete choice experiment with duration. Value in Health, 21(10), 1234-1242. View this article in WRRO
- The Role Of Condition-Specific Preference-Based Measures In Health Technology Assessment. PharmacoEconomics, 35(Suppl 1), 33-41. View this article in WRRO
- INTERNATIONAL REGULATIONS AND RECOMMENDATIONS FOR UTILITY DATA FOR HEALTH TECHNOLOGY ASSESSMENT. PharmacoEconomics, 35(Suppl 1), 11-19. View this article in WRRO
- Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Medical Decision Making, 36(2), 210-222.
- A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale. Medical Decision Making, 35(3), 328-340. View this article in WRRO
- Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.. Value Health, 16(1), 202-210.
All publications
Journal articles
- Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences. Quality of Life Research. View this article in WRRO
- Convergent validity of EQ-5D with core outcomes in dementia: a systematic review. Health and Quality of Life Outcomes, 20(1). View this article in WRRO
- A systematic review of the methodologies and modelling approaches used to generate international EQ-5D-5L value sets. PharmacoEconomics. View this article in WRRO
- Should We Consider Including a Value for "Hope" as an Additional Benefit Within Health Technology Assessment?. Value Health.
- Does changing the age of a child to be considered in 3-level version of EQ-5D-Y discrete choice experiment–based valuation studies affect health preferences?. Value in Health. View this article in WRRO
- The EQ Health and Wellbeing: Overview of the Development of a Measure of Health and Wellbeing and Key Results. Value in Health.
- Adolescent valuation of CARIES-QC-U : a child-centred preference-based measure of dental caries. Health and Quality of Life Outcomes, 20(1). View this article in WRRO
- Measuring what matters: little evidence supporting the content validity of EQ-5D in people with Duchenne muscular dystrophy and their caregivers. Medical Decision Making. View this article in WRRO
- Transforming challenges into opportunities: conducting health preference research during the COVID-19 pandemic and beyond. Quality of Life Research. View this article in WRRO
- Valuing child and adolescent health: a qualitative study on different perspectives and priorities taken by the adult general public. Health and Quality of Life Outcomes, 19. View this article in WRRO
- The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set. Value in Health, 24(6), 862-873.
- Vignette-based utilities: usefulness, limitations, and methodological recommendations. Value in Health, 24(6), 812-821. View this article in WRRO
- Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument. Quality of Life Research. View this article in WRRO
- Development of a new quality of life measure for Duchenne muscular dystrophy using mixed methods. Neurology, 96(19), e2438-e2450. View this article in WRRO
- Deriving a preference-based measure for people with Duchenne Muscular Dystrophy from the DMD-QoL. Value in Health, 24(10), 1499-1510. View this article in WRRO
- What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality adjusted life years? Application to the development of the EQ-HWB?. European Journal of Health Economics, 22(7), 1067-1081. View this article in WRRO
- Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study. BMC Medical Research Methodology, 21. View this article in WRRO
- Discrete choice experiments or best-worst scaling? A qualitative study to determine the suitability of preference elicitation tasks in research with children and young people. Journal of Patient-Reported Outcomes, 5. View this article in WRRO
- A review of the psychometric performance of selected child and adolescent preference-based measures used to produce utilities for child and adolescent health. Value in Health, 24(3), 443-460. View this article in WRRO
- Estimating a preference-based index for mental health from the recovering quality of life measure: valuation of recovering quality of life utility index. Value in Health, 24(2), 281-290. View this article in WRRO
- Selection and validation of a classification system for a child-centred preference-based measure of oral health-related quality of life specific to dental caries. Journal of Patient-Reported Outcomes, 4. View this article in WRRO
- Valuing the AD-5D dementia utility instrument: an estimation of a general population tariff. PharmacoEconomics, 38(8), 871-881. View this article in WRRO
- Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR. Trials, 21(1).
- A review of the methods used to generate utility values in NICE technology assessments for children and adolescents. Value in Health, 23(7), 907-917. View this article in WRRO
- Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Medical Care, 58(6), 566-573. View this article in WRRO
- Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Medical Care, 58(6), 557-565. View this article in WRRO
- Review of valuation methods of preference-based measures of health for economic evaluation in child and adolescent populations: Where are we now and where are we going?. PharmacoEconomics, 38(4), 325-340. View this article in WRRO
- Assessment of the psychometric properties and refinement of the health and self-management in diabetes questionnaire (HASMID). Health and Quality of Life Outcomes, 18(1). View this article in WRRO
- Examining the feasibility and acceptability of valuing the Arabic version of SF-6D in a Lebanese population. International Journal of Environmental Research and Public Health, 17(3). View this article in WRRO
- UK utility weights for the EORTC QLU-C10D. Health Economics, 28(12), 1385-1401. View this article in WRRO
- PROM validation using paper-based or online surveys : data collection methods affect the sociodemographic and health profile of the sample. Value in Health, 22(8), 845-850. View this article in WRRO
- Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses. Heart Failure Reviews, 24(4), 549-563. View this article in WRRO
- An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy, 17(3), 295-313. View this article in WRRO
- MACUSTAR: Entwicklung und klinische Validierung von funktionellen, strukturellen und patientenberichteten Endpunkten bei intermediärer altersabhängiger Makuladegeneration. Der Ophthalmologe, 116(12), 1186-1193.
- Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: A mixed-methods study protocol. BMJ Open, 9. View this article in WRRO
- Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?. The European Journal of Health Economics, 20(2), 245-255. View this article in WRRO
- Future directions in valuing benefits for estimating QALYs: is time up for the EQ-5D?. Value in Health, 22(1), 62-68. View this article in WRRO
- MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration. Ophthalmologica, 241(2), 61-72.
- Estimating a Dutch value set for the paediatric preference-based CHU-9D using a discrete choice experiment with duration. Value in Health, 21(10), 1234-1242. View this article in WRRO
- Estimating a Preference-Based Single Index Measuring the Quality-of-Life Impact of Self-Management for Diabetes. Medical Decision Making, 38(6), 699-707. View this article in WRRO
- Developing a dementia-specific preference-based quality of life measure (AD-5D) in Australia: a valuation study protocol. BMJ Open, 8. View this article in WRRO
- Using a Discrete Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes. Value in Health, 21(1), 69-77. View this article in WRRO
- Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. Phamacoeconomics. View this article in WRRO
- Sourcing and using appropriate health state utility values in economic models in health care. PharmacoEconomics, 35(Suppl 1), 7-9. View this article in WRRO
- The Use Of Mapping To Estimate Health State Utility Values. PharmacoEconomics, 35(Suppl 1), 57-66. View this article in WRRO
- The Role Of Condition-Specific Preference-Based Measures In Health Technology Assessment. PharmacoEconomics, 35(Suppl 1), 33-41. View this article in WRRO
- A REVIEW OF GENERIC PREFERENCE-BASED MEASURES FOR USE IN COST-EFFECTIVENESS MODELS. PharmacoEconomics, 35(Suppl 1), 21-31. View this article in WRRO
- INTERNATIONAL REGULATIONS AND RECOMMENDATIONS FOR UTILITY DATA FOR HEALTH TECHNOLOGY ASSESSMENT. PharmacoEconomics, 35(Suppl 1), 11-19. View this article in WRRO
- Experience-based utility and own health state valuation for a health state classification system: why do it and how to do it. The European Journal of Health Economics. View this article in WRRO
- Developing preference-based measures for diabetes: DHP-3D and DHP-5D. Diabetic Medicine, 34(9), 1264-1275. View this article in WRRO
- Developing a questionnaire to determine the impact of self-management in diabetes: giving people with diabetes a voice. Health and Quality of Life Outcomes, 15(-), ---. View this article in WRRO
- Estimating an exchange rate between the EQ-5D-3L and ASCOT. European Journal of Health Economics. View this article in WRRO
- Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D. Value in Health, 20(4), 687-693. View this article in WRRO
- Predicting Productivity Losses from Health-Related Quality of Life Using Patient Data.. Applied Health Economics and Health Policy. View this article in WRRO
- Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.. Qual Life Res. View this article in WRRO
- Estimating informal care inputs associated with EQ-5D for use in economic evaluation. The European Journal of Health Economics, 17(6), 733-744. View this article in WRRO
- QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research, 25(3), 625-636.
- Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Medical Decision Making, 36(2), 210-222.
- Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness. Applied Health Economics and Health Policy, 14(1), 89-104. View this article in WRRO
- Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 25(3), 637-649.
- Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L. Medical Decision Making, 35(7), 912-926. View this article in WRRO
- Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF. Value in Health, 18(6), 846-855.
- A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale. Medical Decision Making, 35(3), 328-340. View this article in WRRO
- Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma. Health and Quality of Life Outcomes, 13(1). View this article in WRRO
- An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D. Value in Health, 18(1), 52-60. View this article in WRRO
- Comparison of General Population, Patient, and Carer Utility Values for Dementia Health States. Medical Decision Making, 35(1), 68-80. View this article in WRRO
- Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. Health and Quality of Life Outcomes, 12. View this article in WRRO
- Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach. Patient Related Outcome Measures, 5, 119-129. View this article in WRRO
- From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluation. Health and Quality of Life Outcomes, 12(1). View this article in WRRO
- Preparatory study for the revaluation of the EQ-5D tariff: methodology report.. Health Technol Assess, 18(12), vii-191. View this article in WRRO
- Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.. Health Technol Assess, 18(9), 1-224. View this article in WRRO
- Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population.. Epilepsy Behav, 36, 12-17.
- Exploring the consistency of the SF-6D.. Value Health, 16(6), 1023-1031.
- Common scale valuations across different preference-based measures: estimation using rank data.. Med Decis Making, 33(6), 839-852.
- Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.. Value Health, 16(2), 373-384.
- Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.. Health Technol Assess, 17(5), v-140.
- Binary choice health state valuation and mode of administration: head-to-head comparison of online and CAPI.. Value Health, 16(1), 104-113. View this article in WRRO
- Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.. Value Health, 16(1), 202-210.
- Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D.. Med Decis Making, 33(3), 381-395.
- Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.. Value Health, 15(8), 1059-1068.
- Response to Comments on Mulhern et al., "Improving the Measurement of QALYs in Dementia: Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis".. Value Health, 15(5), 787-788.
- Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).. Health Technol Assess, 16(32), 1-114.
- Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.. Value Health, 15(3), 495-503.
- The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy and Behavior, 24(1), 36-43.
- Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-proxy. Value in Health, 15(2), 346-356.
- Improving the measurement of QALYs in dementia: Developing patient- and carer-reported health state classification systems using Rasch analysis. Value in Health, 15(2), 323-333. View this article in WRRO
- Androgen deprivation therapy for prostate cancer prevention: What impact do related adverse events have on quality of life?. Health Outcomes Research in Medicine, 3(3).
- Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale.. Eur J Health Econ, 13(5), 575-587.
- It's all in the name, or is it? The impact of labeling on health state values.. Med Decis Making, 32(1), 31-40.
- Reducing the Floor Effect in the SF-6D: A Feasibility Study. Applied Research in Quality of Life, 7(2), 193-208.
- Valuing states from multiple measures on the same visual analogue sale: A feasibility study. Health Economics, 21(6), 715-729.
- Deriving a preference-based measure for cancer using the EORTC QLQ-C30.. Value Health, 14(5), 721-731. View this article in WRRO
- Estimating the SF-6D value set for a population-based sample of Brazilians. Value in Health, 14(5 SUPPL.).
- The impact of adding an extra dimension to a preference-based measure.. Soc Sci Med, 73(2), 245-253.
- Do Portuguese and UK health state values differ across valuation methods?. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 20(4), 609-619.
- Mapping onto Eq-5 D for patients in poor health.. Health Qual Life Outcomes, 8, 141. View this article in WRRO
- PIH32 TREATMENTS TO PREVENT PROSTATE CANCER AND THEIR IMPACT ON HEALTH RELATED QUALITY OF LIFE. Value in Health, 13(7), A380-A381.
- Developing preference-based health measures: using Rasch analysis to generate health state values.. Qual Life Res, 19(6), 907-917.
- A Portuguese Value Set for the SF-6D. VALUE HEALTH, 13(5), 624-630.
- A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures.. Eur J Health Econ, 11(2), 215-225.
- Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?. Health Qual Life Outcomes, 7, 27.
- Ethical principles and economic analysis. Journal of Interdisciplinary Economics, 16(3), 247-269.
- Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?. PharmacoEconomics.
- Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration. JAMA Ophthalmology.
- What Matters for Evaluating the Quality of Mental Healthcare? Identifying Important Aspects in Qualitative Focus Groups with Service Users and Frontline Mental Health Professionals. Patient.
- View this article in WRRO
- View this article in WRRO
Chapters
- Preference-Based Measures of Health-Related Quality of Life, Encyclopedia of Quality of Life and Well-Being Research (pp. 1-3). Springer International Publishing
- Preference-Weighted Health States, Encyclopedia of Quality of Life and Well-Being Research (pp. 5028-5030). Springer Netherlands
- Preference-Based Measures of Health-Related Quality of Life, Encyclopedia of Quality of Life and Well-Being Research (pp. 5026-5028). Springer Netherlands
- Multiattribute Utility Instruments: Condition-Specific Versions, Encyclopedia of Health Economics (pp. 358-365). Elsevier
- Health Utility Measurement (pp. 787-813). Oxford University Press
Conference proceedings papers
- The Hypo-RESOLVE quality of life (QoL) instrument: A study protocol for the development of a new preference-based measure designed to capture the impact of hypoglycaemia on QoL. Quality of Life Research, Vol. 31(Suppl 2) (pp S91-S91). Prague, Czech Republic, 19 October 2022 - 19 October 2022.
- PCR175 Valuation of SF-6D Health States: Is It Feasible and Acceptable in a Lebanese Population. Value in Health, Vol. 25(7) (pp S574-S574)
- PMH29 ESTIMATING A PREFERENCE-BASE INDEX FROM THE RECOVERING QUALITY OF LIFE MEASURE FOR ECONOMIC EVALUATION IN THE AREA OF MENTAL HEALTH: VALUATION OF REQOL-UI. Value in Health, Vol. 22 (pp S685-S686)
- PRO130 PROJECT HERCULES: CONSTRUCTION OF A NEW PREFERENCE-BASED MEASURE OF QUALITY OF LIFE FOR DUCHENNE MUSCULAR DYSTROPHY (DMD). Value in Health, Vol. 22 (pp S865-S865)
- PSY215 - MEASURING QUALITY OF LIFE FOR ECONOMIC EVALUATION IN DUCHENNE MUSCULAR DYSTROPHY (DMD) FROM CHILDHOOD TO ADULTHOOD: PROTOCOL FOR A NEW PREFERENCE-BASED MEASURE. Value in Health, Vol. 21 (pp S473-S473)
- PRM190 - METHODS USED TO VALUE HEALTH RELATED QUALITY IN A SYSTEMATIC REVIEW OF COST-UTILITY ANALYSES IN HEART FAILURE. Value in Health, Vol. 21 (pp S388-S389)
- 25th Annual Conference of the International Society for Quality of Life Research. Quality of Life Research, Vol. 27(S1) (pp 1-190)
- Cross-Country Comparison Of Cancer-Specific Multi-Attribute Utility Instruments (Mauis): Relative Weighting And Ranking Of Health-Related Quality Of Life (Hrql) Domains In Country-Specific Utility Algorithms. Value in Health, Vol. 21 (pp S2-S3)
- Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Oxford 2017: Advances in Patient Reported Outcomes Research. Health and Quality of Life Outcomes, Vol. 15(S1) View this article in WRRO
- Two New Cancer-Specific Multi-Attribute Utility Instruments: EORTC QLU-C10D and FACT-8D. Value in Health, Vol. 19(7) (pp A807-A807)
- Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research. Health and Quality of Life Outcomes, Vol. 14(Suppl 1), 9 June 2016 - 9 June 2016. View this article in WRRO
- View this article in WRRO
- A COMPARISON OF PATIENT AND GENERAL-POPULATION UTILITY VALUES FOR ADVANCED MELANOMA IN HEALTH ECONOMIC MODELLING. VALUE IN HEALTH, Vol. 15(7) (pp A285-A285)
- THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. VALUE IN HEALTH, Vol. 15(4) (pp A225-A225)
- ESTIMATING QUALITY OF LIFE IN ADVANCED MELANOMA; A COMPARISON OF STANDARD GAMBLE, SF-36 MAPPED, AND EORTC QLQ-C30 MAPPED UTILITIES. VALUE IN HEALTH, Vol. 14(7) (pp A461-A462)
- THE IMPACT OF CONDITION LABELLING ON HEALTH STATE VALUES. VALUE IN HEALTH, Vol. 14(7) (pp A457-A457)
- MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH. VALUE IN HEALTH, Vol. 14(7) (pp A242-A242)
Reports
- View this article in WRRO
- View this article in WRRO
- View this article in WRRO
- View this article in WRRO
- View this article in WRRO
Scholarly editions
Posters
Datasets
- Psychometric data for 'A new quality of life questionnaire for use in Duchenne muscular dystrophy: the DMD-QoL'.
- Supplementary files for 'A new quality of life questionnaire for use in Duchenne muscular dystrophy: the DMD-QoL'.
Other
- Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research. View this article in WRRO
- Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research, 25(10), 2683-2683.
- Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 25(9), 2401-2401.
- Erratum to: Reducing the Floor Effect in the SF-6D: A Feasibility Study. Applied Research in Quality of Life, 11(1), 329-329.
- FDA on PROMs: Two important points. BMJ (Online), 341(7776), 746.
Preprints
- Development of the CFQ-R-8D: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised, Research Square Platform LLC.
- A systematic review of the methodologies and modelling approaches used to generate international EQ-5D-5L value sets. PharmacoEconomics. View this article in WRRO
- Research group
-
I am a member of EEPRU, the Department of Health Policy Research Unit in the Economic Methods of Evaluation of Health and Care Interventions. I am also on the editorial board for Medical Decision Making.
PhD students:
- Hannah Hussain
- Haode Wang
- Teaching interests
-
My teaching interests lie in health economics, in particular QALYs, utilities and outcome measurement.
I am interested in supervising research students in topics/areas related to measuring and valuing health, in particular deriving, estimating and using utility data for health technology assessment.